{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:11:27Z","timestamp":1760080287290,"version":"3.37.3"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["A5239"],"award-info":[{"award-number":["A5239"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","award":["10-001308"],"award-info":[{"award-number":["10-001308"]}],"id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","award":["14-125"],"award-info":[{"award-number":["14-125"]}],"id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0215725","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T20:37:12Z","timestamp":1556570232000},"page":"e0215725","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Exploring the hereditary background of renal cancer in Denmark"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5428-0739","authenticated-orcid":true,"given":"Maria Bejerholm","family":"Christensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Wadt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uffe Birk","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte Kvist","family":"Lautrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Bojesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotte Nylandsted","family":"Krogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas van","family":"Overeem Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eururo.2014.04.029","article-title":"Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity","volume":"67","author":"B Shuch","year":"2015","journal-title":"Eur Urol"},{"key":"ref2","unstructured":"Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint \u00c5, et al. Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries; 2018 [cited 2018 Aug 1]. Database: NORDCAN [Internet]. Available from <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www-dep.iarc.fr\/NORDCAN\/english\/StatsFact.asp?cancer=290&country=208\" xlink:type=\"simple\">http:\/\/www-dep.iarc.fr\/NORDCAN\/english\/StatsFact.asp?cancer=290&amp;country=208<\/ext-link>."},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.sult.2009.03.003","article-title":"Renal Cell Carcinoma: Recent Advances in Genetics and Imaging","volume":"30","author":"S Choudhary","year":"2009","journal-title":"Semin Ultrasound, CT MRI"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0022-5347(05)67892-5","article-title":"Renal cell carcinoma: prognostic significance of incidentally detected tumors","volume":"163","author":"K-H Tsui","year":"2000","journal-title":"J Urol"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrurol.2010.46","article-title":"Epidemiology and risk factors for kidney cancer","volume":"7","author":"W-H Chow","year":"2010","journal-title":"Nat Rev Urol"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2362.2010.02270.x","article-title":"Hereditary causes of kidney tumours","volume":"40","author":"PH Axwijk","year":"2010","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.eururo.2010.08.031","article-title":"Hereditary Renal Cancer Syndromes: An Update of a Systematic Review","volume":"58","author":"J Verine","year":"2010","journal-title":"Eur Urol"},{"key":"ref8","article-title":"Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management","author":"E Maher","year":"2018","journal-title":"World J Urol"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jclinpath-2016-203866","article-title":"BAP1: gene of the month","volume":"69","author":"A Wang","year":"2016","journal-title":"J Clin Pathol"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families","volume":"7","author":"C-NJ Njauw","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/pcmr.12006","article-title":"A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma","volume":"25","author":"K Wadt","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gcc.22129","article-title":"Expanding the Clinical Phenotype of Hereditary BAP1 Cancer Predisposition Syndrome, Reporting Three New Cases","volume":"53","author":"R Pilarski","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1309\/AJCPG8LFJC0DHDQT","article-title":"Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations","volume":"143","author":"MC Mochel","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/cge.12472","article-title":"Germline BAP1 mutations predispose also to multiple basal cell carcinomas","volume":"88","author":"A de la Fouchardi\u00e8re","year":"2015","journal-title":"Clin Genet"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/PPO.0b013e3182a102d1","article-title":"PBRM1 and BAP1 as Novel Targets for Renal Cell Carcinoma","volume":"19","author":"J Brugarolas","year":"2013","journal-title":"Cancer J"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"S Pe\u00f1a-Llopis","year":"2012","journal-title":"Nat Genet"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 Mutations Predispose to Renal Cell Carcinomas","volume":"92","author":"T Popova","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1158\/1541-7786.MCR-13-0111","article-title":"A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma","volume":"11","author":"MN Farley","year":"2013","journal-title":"Mol Cancer Res"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamadermatol.2017.2330","article-title":"Genotypic and Phenotypic Features of BAP1 Cancer Syndrome A Report of 8 New Families and Review of Cases in the Literature","volume":"153","author":"AM Haugh","year":"2017","journal-title":"JAMA Dermatology"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/labinvest.2017.9","article-title":"The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology","volume":"97","author":"A Kawakami","year":"2017","journal-title":"Lab Investig"},{"issue":"7375","key":"ref21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"C Bertolotto","year":"2011","journal-title":"Nature"},{"issue":"1\u20132","key":"ref22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejcb.2013.10.002","article-title":"A germline oncogenic MITF mutation and tumor susceptibility","volume":"93","author":"BB Paillerets","year":"2014","journal-title":"Eur J Cell Biol"},{"issue":"38","key":"ref23","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1038\/sj.onc.1202998","article-title":"The INK4 family of cell cycle inhibitors in cancer","volume":"18","author":"MF Roussel","year":"1999","journal-title":"Oncogene"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1158\/2159-8290.CD-14-1096","article-title":"Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma","volume":"5","author":"M Jafri","year":"2015","journal-title":"Cancer Discov"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"e0122662","DOI":"10.1371\/journal.pone.0122662","article-title":"Molecular Characterization of Melanoma Cases in Denmark Suspected of Genetic Predisposition","volume":"10","author":"KAW Wadt","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","article-title":"Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results","volume":"29","author":"SE Plon","year":"2008","journal-title":"Hum Mutat"},{"issue":"20","key":"ref27","doi-asserted-by":"crossref","first-page":"11661","DOI":"10.1073\/pnas.95.20.11661","article-title":"pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation","volume":"95","author":"O Iliopoulos","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/sj.onc.1202473","article-title":"Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity","volume":"18","author":"C Blankenship","year":"1999","journal-title":"Oncogene"},{"issue":"15","key":"ref29","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.1073\/pnas.95.15.8817","article-title":"A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor","volume":"95","author":"A Schoenfeld","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1038\/srep12605","article-title":"Isoform-specific interactions of the von Hippel-Lindau tumor suppressor protein","volume":"5","author":"G Minervini","year":"2015","journal-title":"Sci Rep"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000443311","article-title":"The Microphthalmia-Associated Transcription Factor p.E318K Mutation Does Not Play a Major Role in Sporadic Renal Cell Tumors from Caucasian Patients","volume":"83","author":"CG Stoehr","year":"2016","journal-title":"Pathobiology"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cancergen.2014.03.003","article-title":"Prevalence of the E318K and V320I MITF germline mutations in Polish cancer patients and multiorgan cancer risk-a population-based study","volume":"207","author":"T Gromowski","year":"2014","journal-title":"Cancer Genet"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1210\/jc.2016-2103","article-title":"The MITF, p.E318K variant, as a Risk Factor for Pheochromocytoma and Paraganglioma","volume":"101","author":"LJ Castro-Vega","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/jmedgenet-2014-102912","article-title":"A germline mutation in PBRM1 predisposes to renal cell carcinoma","volume":"52","author":"PR Benusiglio","year":"2015","journal-title":"J Med Genet"},{"article-title":"Danskernes Sundhed\u2014Den Nationale Sundhedsprofil 2017","year":"2017","author":"HAR Jensen","key":"ref35"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.eururo.2005.11.035","article-title":"2004 WHO Classification of the Renal Tumors of the Adults","volume":"49","author":"A Lopez-Beltran","year":"2006","journal-title":"Eur Urol"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.eururo.2011.06.047","article-title":"Current Pathology Keys of Renal Cell Carcinoma","volume":"60","author":"F Algaba","year":"2011","journal-title":"Eur Urol"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs\u2014Part A: Renal, Penile, and Testicular Tumours","volume":"70","author":"H Moch","year":"2016","journal-title":"Eur Urol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0215725","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:15:28Z","timestamp":1589008528000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0215725"}},"subtitle":[],"editor":[{"given":"Amanda Ewart","family":"Toland","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0215725","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,4,29]]}}}